We bought back our popular 3 CEOs session to WinterTech! Here, Indu sits down with CEO Owen Tripp from Grand Rounds to discuss the secret behind their success.
In recent years we’ve seen the fields of life science and health technology steadily intertwine as the rise of wearable sensors and other connected devices continue to evolve alongside advanced genomic analysis and big data’s impact on personalized medicine. In this panel, Indu along with Justin, David, Carolyne, Jeffrey and Leslie discuss how these fields mutually benefiting from each other and how they are making health care more accurate, accessible, and affordable.
Matthew Holt talks one-on-one with Bryan Roberts, who invested in athenahealth, co-founded Castlight, and generally was about 5 years ahead of everyone else investing in digital health.
Matthew Holt chats with a Silicon Valley VC, Rebecca Lynn of Canvas, and Jeff Tangney, CEO of Doximity. Canvas was the lead investor in Doximity’s Series B. This conversation gives an intimate detailed look at the investment criteria both sides face, the evolution of the business model, and how the two work together.
Indu Subiaya sits down for a one-on-one discussion with Silicon Valley VC, Vinod Khosla to discuss his thoughts on the digital health care space, his investments, and more.
Matthew and Indu welcome everyone to WinterTech 2016 at Julia Morgan Ballroom and discuss the featured speakers.
Indu sits down with Jeff Arnold, CEO of Sharecare, to discuss the rise and journey of Sharecare since launching at Health 2.0 five years ago. Sharecare is a health and wellness engagement platform that provides people with personalized resources to help them live their healthiest lives.
Indu Subaiya sits down with Comcast’s Vice President of Strategic Development, Marc Siry to discuss how Comcast is engaging customers in innovative ways to deliver health and wellness content with their new myPregnancy app.
Health 2.0 is just getting into the mainstream. Other tools and approaches like disease management and patient safety seem to have been held back because they can’t prove the elusive ROI. Others, like EMRs & ACOs and almost any med tech intervention and drug you can think of seem to roll right ahead. Thus, how should we think about the business future and likely impact of the technologies we show on stage? What should we all be saying to the health care system? Patient safety expert and all around witty gadfly Michael Millenson joins Matthew Holt to make some suggestions.